Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2
Immunity, Inflammation and Disease · 2026-04 · 14 (4)
DOI: 10.1002/iid3.70441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 26.04.2026. Verfasst von Moyra Machado Portilho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulin M, Antibodies, Viral, COVID-19. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico, CoordenaÇÃo de AperfeiÇoamento de Pessoal de NÍvel Superior.
Abstract (Originalsprache)
Background
Despite widespread vaccination, SARS‐CoV‐2 transmission continues, and serological testing remains relevant for selected diagnostic scenarios and population‐based assessments of antibody responses. Rapid diagnostic tests (RDTs) for SARS‐CoV‐2 antibodies are attractive for field use and decentralized settings, but their diagnostic performance varies and requires independent evaluation. We assessed the performance of three commercially available lateral flow RDTs (PANBIO™ COVID‐19 IgG/IgM Rapid Test Device, Bio‐Manguinhos‐Fiocruz TR COVID‐19 (IgM‐IgG), and Bio‐Manguinhos‐Fiocruz TR DPP® COVID‐19 IgM/IgG) in Salvador, Brazil.
Methods
Using blind analyses, we evaluated 257 serum samples from RT‐PCR‐confirmed cases and 199 control samples from individuals with other febrile illnesses or healthy donors collected before and during the pandemic.
Results
Overall sensitivity for IgM or IgG detection was limited across all tests (52%–58%), while specificity was high for two assays (97%–98%) and lower for one (80%). Sensitivity peaked between 11 and 20 days after symptom onset (80%–91%) and declined thereafter. Among 75 vaccinated individuals without prior COVID‐19, antibody positivity ranged from 39% to 55%.
Conclusion
These findings indicate that the evaluated RDTs had high specificity but insufficient sensitivity for reliable clinical diagnosis or for assessing vaccination status in serological surveys. Our results support cautious use of these assays and highlight the need for more accurate and robust antibody‐based rapid tests to strengthen immunological surveillance and public health preparedness in the post‐pandemic period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
- Secretaria Municipal de Saúde de Salvador, Salvador, Brazil.
- Escola de Medicina Veterinária e Zootecnia, Universidade Federal da Bahia, Salvador, Brazil.
- Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.
- Yale School of Public Health, New Haven, Connecticut, USA.
ORCID-Profile: Stephane Fraga de Oliveira Tosta
Förderung
- Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico
- CoordenaÇÃo de AperfeiÇoamento de Pessoal de NÍvel Superior
Zitieren
APA
Portilho, M. M., de Oliveira Tosta, S. F., Pellizzaro, M., Dos Anjos, R. O., de Oliveira, E. C., de Santana, P. D. S. N., Dos Santos Moreira, P. S., Jacob-Nascimento, L. C., da Silva Souza, M. M., Mothé, D. B., Brodskyn, C., Reis, M. G., Cardoso, C. W., & Ribeiro, G. S. (2026). Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70441
Vancouver
Portilho MM, de Oliveira Tosta SF, Pellizzaro M, Dos Anjos RO, de Oliveira EC, de Santana PDSN, et al. Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70441
BibTeX
@article{Portilho2026,
author = {Portilho, Moyra Machado and de Oliveira Tosta, Stephane Fraga and Pellizzaro, Maysa and Dos Anjos, Rosângela Oliveira and de Oliveira, Elaine Carvalho and de Santana, Pamela Dos Santos Nascimento and Dos Santos Moreira, Patrícia Sousa and Jacob-Nascimento, Leile Camila and da Silva Souza, Mirela Maisa and Mothé, Deborah Bittencourt and Brodskyn, Cláudia and Reis, Mitermayer Galvão and Cardoso, Cristiane Wanderley and Ribeiro, Guilherme Sousa},
title = {Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/iid3.70441}
}
EUVIMED